Analysis of basement membrane structure and inflammation during the development of esophageal squamous cell carcinoma in the Chinese Chaoshan high risk region

Cancer Investigation

Volumn 26, Issue 3, 2008, Pages 296-305

  Zhang, Guo Hong ^a   Su, Min ^a   Tian, Dong Ping ^a   Huang, Hai Hua ^a   Wu, Xian Ying ^a   Zheng, Rui Ming ^a   Li, Qiao Shan ^a  

^a SHANTOU UNIVERSITY MEDICAL COLLEGE   (China)

Author keywords

Basement membrane; ERK MAPK signaling pathway; Esophageal carcinogenesis; Inflammation; Ki67

Indexed keywords

BETA1 INTEGRIN; EOSIN; HEMATOXYLIN; KI 67 ANTIGEN; LAMININ; MITOGEN ACTIVATED PROTEIN KINASE;

ARTICLE; BASEMENT MEMBRANE; CANCER GROWTH; CANCER STAGING; CELL PROLIFERATION; CHINESE; CONTROLLED STUDY; ENZYME ACTIVATION; ESOPHAGUS CARCINOMA; HIGH RISK POPULATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MEMBRANE STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY; WESTERN BLOTTING;

BASEMENT MEMBRANE; BLOTTING, WESTERN; CARCINOMA, SQUAMOUS CELL; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHINA; ESOPHAGEAL NEOPLASMS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INTEGRIN BETA CHAINS; KI-67 ANTIGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK FACTORS; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS;

EID: 40149107735     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900701683901     Document Type: Article

References (32)

1. Jemal, A.; Murray, T.; Samuels, A.; Ghafoor, A. Ward, E.; Thun, M.J. Cancer statistics, 2003. CA Cancer J. Clin. 2003, 53, 5-26.
2. Su, M.; Li, X.Y.; Tian, D.P.; Wu, M.Y.; Wu, X.Y.; Lu, S.M.; Huang, H.H.; Li, D.R.; Zheng, Z.C.; Xu, X.H. Clinicopathologic analysis of esophageal and cardiac cancers and survey of molecular expression on tissue microarrays in Chaoshan littoral of China. World J. Gastroenterol 2004, 10, 2163-2167.
3. Enzinger, P.C.; Mayer, R.J. Esophageal Cancer. The New England Journal of Medicine 2003, 349, 2241-2252.
4. Su, H.; Hu, N.; Shih, J.; Hu, Y.; Wang, Q.H.; Chuang, E.Y.; Roth, M.J.; Wang, C.; Goldstein, A.M.; Ding, T.; Dawsey, S.M.; Giffen, C.; Emmert Buck, M.R.; Taylor, P.R. Gene expression analysis of esophageal squamous cell carcinoma reveals consistent molecular profiles related to a family history of upper gastrointestinal cancer. Cancer Res 2003, 63, 3872-3876.
5. Nie, Y.; Liao, J.; Zhao, X.; Song, Y.; Yang, G.Y.; Wang, L.D.; Yang, C.S. Detection of multiple gene hypermethylation in the development of esophageal squamous cell carcinoma. Carcinogenesis 2002, 23 1713-1720.
6. Hao, M.W.; Liang, Y.R.; Liu, Y.F.; Liu, L.; Wu, M.Y.; Yang, H.X. Transcription factor EGR-1 inhibits growth of hepatocellular carcinoma and esophageal carcinoma cell lines. World J. Gastroenterol 2002, 8.
7. Wu, M.Y.; Zhuang, C.Z.; Yang, H.X.; Liang, Y.R. Expression of Egr-1 c-fos and cyclin D1 in esophageal cancer and its precursors: An immunohistochemical and in situ hybridization study. World J. Gastroenterol 2004, 10, 476-480.
8. Shinohara, M.; Aoki, T.; Sato, S.; Takagi, Y.; Osaka, Y.; Koyanagi, Y.; Hatooka, S.; Shinoda, M. Cell cycle-regulated factors in esophageal cancer. Dis. Esophagus 2002, 15, 149-154.
9. Gibson, M.K.; Abraham, S.C.; Wu, T.T.; Burtness, B.; Heitmiller, R.F.; Heath, E.; Forastiere, A. Epidermal growth factor receptor, p53 mutation, and pathological response predict survival in patients with locally advanced esophageal cancer treated with preoperative chemoradiotherapy. Clinical Cancer Research 2003, 9, 6461-6468.
10. Arteaga, C.L. Epidermal growth factor receptor dependence in human tumors: more than just expression? The Oncologist 2002, 7(suppl 4), 31-39.
11. Ardies, C.M. Inflammation as cause for scar cancers of the lung. Integr Cancer Ther. 2003, 2, 238-246.
12. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
13. Goldstein, S.R.; Yang, G.Y.; Chen, X.; Curtis, S.K.; Yang, C.S. Studies of iron deposits, inducible nitric oxide synthase and nitrotyrosine in a rat model for esophageal adenocarcinoma. Carcinogenesis 1998, 19, 1445-1449.
14. Miosge, N. The ultrastructural composition of basement membranes in vivo. Histol. Histopathol. 2001, 16, 1239-1248.
15. Baba, K.; Kuwano, H.; Kitamura, K.; Sugimachi, K. Carcinomatous invasion and lymphocyte infiltration in early esophageal carcinoma with special regard to the basement membrane. An immunohistochemical study. Hepatogastroenterology 1993, 40, 226-231.
16. Schwartz, M.A.; Assoian, R.K. Integrins and cell proliferation regulation of cyclin-dependent kinases via cytoplasmic signaling pathways. Journal of Cell Science 2001, 114, 2553-2560.
17. Souza, R.F.; Shewmake, K.; Pearson, S.; Sarosi, G.A. Jr; Feagins, L.A.; Ramirez, R.D.; Terada, L.S.; Spechler, S.J. Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am. J. Physiol. Gastrointest Liver Physiol. 2004, 287, 743-748.
18. Yamamoto, H.; Itoh, F.; Iku, S.; Hosokawa, M.; Imai, K. Expression of the γ 2 Chain of Laminin-5 at the Invasive Front Is Associated with Recurrence and Poor Prognosis in Human Esophageal Squamous Cell Carcinoma. Clin. Cancer Res. 2001, 7, 896-900.
19. Li, J.Y.; Ershow, A.G.; Chen, Z.J.; Wacholder, S.; Li, G.Y.; Guo, W. A case-control study of cancer of the esophagus and gastric cardia in Linxian. Int. J. Cancer 1989, 43, 755-761.
20. Foss, A.J.; Alexander, R.A.; Hungerford, J.L.; Harris, A.L.; Cree, I.A.; Lightman, S. Reassessment of the PAS patterns in uveal melanoma. Br. J. Ophthalmol. 1997, 81, 240-246.
21. Mori, M.; Shimono, R.; Kido, A.; Kuwano, H.; Akazawa, K.; Sugimachi, K. Distribution of basement membrane antigens in human esophageal lesions: an immunohistochemical study. Int. J. Cancer 1991, 47, 839-842.
22. Buttar, N.S.; Wang, K.K.; Leontovich, O.; Westcott, J.Y.; Pacifico, R.J.; Anderson, M.A.; Krishnadath, K.K.; Lutzke, L.S.; Burgart, L.J. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus. Gastroenterology 2002, 122, 1101-1112.
23. Terry, P.; Lagergren, J.; Ye, W.; Nyren, O.; Wolk, A. Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer 2000, 87, 750-754.
24. Shaheen, N.; Ransohoff, D.F. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: scientific review. JAMA 2002, 287, 1972-1981.
25. Dent, J.; Bremner, C.G.; Collen, M.J. Barrett's oesophagus. J. Gastroenterol Hepatol 1991, 6, 1-22.
26. Macarthur, M.; Hold, G.L.; El-Omar, E.M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am. J. Physiol. Gastrointest Liver Physiol. 2004, 286, 515-520.
27. Daly, J.M.; Fry, W.A.; Little, A.G.; Winchester, D.P.; McKee, R.F.; Stewart. A.K.; Fremgen, A.M. Esophageal cancer: results of an American College of Surgeons Patient Care Evaluation Study. J. Am. Coll. Surg. 2000, 190, 562-572.
28. Seery, J.P. Stem cells of the oesophageal epithelium. Journal of Cell Science 2002, 115, 1783-1789.
29. Reya, T.; Morrison, S.J.; Clarke, M.F.; Weissman, I.L. Stem cells, cancer, and cancer stem cells. Nature 2001, 41, 105-111.
30. Nair, K.S.; Naidoo, R.; Chetty, R. Expression of cell adhesion molecules in oesophageal carcinoma and its prognostic value. Journal of Clinical Pathology 2005, 58, 343-351.
31. Marx, J. Mutant stem cells may seed cancer. Science 2003, 301, 1308-1310.
32. Wei, Z.; Hui, T.L. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Research 2002, 12, 9-18.